Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia
Launched by KUNYUE LI · Apr 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how intravenous vitamin C might help reduce fever in women during labor after receiving an epidural for pain relief. Fever during labor can affect both mothers and their babies, so the researchers want to see if giving vitamin C can improve health outcomes for both. The study is currently looking for participants who are expecting a single baby, are in the right position for delivery, and are planning to have a vaginal birth with an epidural.
To be part of this trial, women must be at full term and meet certain health criteria, such as not having a fever before the epidural or any serious medical conditions. If eligible, participants will receive vitamin C during labor and be monitored for any effects on fever and overall health. This research aims to provide valuable information about potential preventive treatments for fever during labor.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • single-fetus, head position, and full-term vaginal delivery receiving epidural labor analgesia.
- Exclusion Criteria:
- • have a fever before epidural analgesia, acute infection on admission, incomplete baseline data, fatal fetal malformations or comorbidities, duration from admission to delivery of more than 72 hours or less than 3 hours, or an American Society of Anesthesiologists (ASA) classification of ≥ Ⅲ.
About Kunyue Li
Kunyue Li is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing effective therapeutic solutions, Kunyue Li collaborates with leading researchers and healthcare professionals to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. The organization prioritizes patient safety and data integrity, leveraging state-of-the-art methodologies to enhance the efficiency and success of clinical studies. Through its commitment to transparency and collaboration, Kunyue Li aims to contribute significantly to the improvement of healthcare outcomes and the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zhengzhou, Henan, China
Patients applied
Trial Officials
Tao Wang, PhD
Study Director
the Third Affilated Hospital of Zhengzhou University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported